{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:37:52Z","timestamp":1790127472275,"version":"4.0.1"},"reference-count":32,"publisher":"Japan Atherosclerosis Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2020,10,1]]},"DOI":"10.5551\/jat.52506","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T22:04:57Z","timestamp":1579903497000},"page":"1053-1067","source":"Crossref","is-referenced-by-count":23,"title":["Identification of Plasma Inositol and Indoxyl Sulfate as Novel Biomarker Candidates for Atherosclerosis in Patients with Type 2 Diabetes. -Findings from Metabolome Analysis Using GC\/MS-"],"prefix":"10.5551","volume":"27","author":[{"given":"Kazuo","family":"Omori","sequence":"first","affiliation":[{"name":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Katakami","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine"},{"name":"Department of Metabolism and Atherosclerosis, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoya","family":"Arakawa","sequence":"additional","affiliation":[{"name":"Laboratory of Bioresource Engineering, Department of Biotechnology, Graduate School of Engineering, Osaka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyo","family":"Ninomiya","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyoshi","family":"Takahara","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine"},{"name":"Department of Diabetes Care Medicine, Graduate School of Medicine, Osaka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taka-aki","family":"Matsuoka","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tsugawa","sequence":"additional","affiliation":[{"name":"RIKEN Center for Sustainable Resource Science, Yokohama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Furuno","sequence":"additional","affiliation":[{"name":"Laboratory of Bioresource Engineering, Department of Biotechnology, Graduate School of Engineering, Osaka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Bamba","sequence":"additional","affiliation":[{"name":"Division of Metabolomics, Medical Institute of Bioregulation, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Fukusaki","sequence":"additional","affiliation":[{"name":"Laboratory of Bioresource Engineering, Department of Biotechnology, Graduate School of Engineering, Osaka University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Department of Metabolic Medicine, Osaka University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Eckel RH, Kahn R, Robertson RM, Rizza RA. Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation, 2006; 113: 2943-2946","DOI":"10.1161\/CIRCULATIONAHA.106.176583"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Stephens JW, Ambler G, Vallance P, Betteridge DJ, Humphries SE, Hurel SJ. Cardiovascular risk and diabetes. Are the methods of risk prediction satisfactory? Eur J Cardiovasc Prev Rehabil, 2004; 11: 521-528","DOI":"10.1097\/00149831-200412000-00013"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Simmons RK, Coleman RL, Price HC, Holman RR, Khaw KT, Wareham NJ, Griffin SJ. Performance of the UK Prospective Diabetes Study risk engine and the Framingham risk equations in estimating cardiovascular disease in the EPIC- Norfolk Cohort. Diabetes Care, 2009; 32: 708-713","DOI":"10.2337\/dc08-1918"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) van Dieren S, Peelen LM, N\u00f6thlings U, van der Schouw YT, Rutten GE, Spijkerman AM, van der A DL, Sluik D, Boeing H, Moons KG, Beulens JW. External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes. Diabetologia, 2011; 54: 264-270","DOI":"10.1007\/s00125-010-1960-0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Haneda M, Noda M, Origasa H, Noto H, Yabe D, Fujita Y, Goto A, Kondo T, Araki E. Japanese Clinical Practice Guideline for Diabetes 2016. J Diabetes Investig, 2018; 9: 1-45","DOI":"10.1111\/jdi.12810"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Miida T, Nishimura K, Hirayama S, Miyamoto Y, Nakamura M, Masuda D, Yamashita S, Ushiyama M, Komori T, Fujita N, Yokoyama S, Teramoto T. Homogeneous Assays for LDL-C and HDL-C are Reliable in Both the Postprandial and Fasting State. J Atheroscler Thromb, 2017; 24: 583-599","DOI":"10.5551\/jat.40006"},{"key":"7","unstructured":"7) Japan Diabetes Society, Treatment Guide for Diabetes Editorial Committee: Diabetes mellitus treatment guideline based on scientific ground (revised edition 2). Volume 1. Edited by Japan Diabetes Society. Tokyo, Japan: Nankodo; 2007: 257-272"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis, 2009; 53: 982-992","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Terminology and Diagnostic Criteria Committee JSoUiM: Standard method for ultrasound evaluation of carotid artery lesions. J Med Ultrason, 2009; 36: 219-226","DOI":"10.1007\/s10396-009-0238-y"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creger MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J a d Vogel R. Guidelined for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of International Brachial Artery Reactivity Tasf Force. J Am Coll Carotid, 2002; 39: 257-265","DOI":"10.1016\/S0735-1097(01)01746-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Tomiyama H, Higashi Y, Takase B, Node K, Sata M, Inoue T, Ishibashi Y, Ueda S, Shimada K and Yamashina A. Relationships among hyperuricemia, metabolic syndrome, and endotherial function. Am J Hypertens, 2011; 24: 770-774","DOI":"10.1038\/ajh.2011.55"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12) Hiroyo Ninomiya, Naoto Katakami, Ihoko Sato, Saeko Osawa, Yuichi Yamamoto, Mitsuyoshi Takahara, Dan Kawamori, Taka-aki Matsuoka, Iichiro Shimomura. Association between subclinical atherosclerosis markers and the level of accumulated advanced glycation end-products in the skin of patients with diabetes. J Atheroscler Thromb, 2018; doi: 10.5551\/jat.44859","DOI":"10.5551\/jat.44859"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Tsugawa H, Cajka T, Kind T, Ma Y, Higgins B, Ikeda K, Kanazawa M, VanderGheynst J, Fiehn O, Arita M. MS-DIAL: data-independent MS\/MS deconvolution for comprehensive metabolome analysis. Nat Methods, 2015; 12: 523-526","DOI":"10.1038\/nmeth.3393"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Tsugawa H, Kanazawa M, Ogiwara A, Arita M. MRMPROBS suite for metabolomics using large-scale MRM assays. Bioinformatics, 2014; 30: 2379-2380","DOI":"10.1093\/bioinformatics\/btu203"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, Brown M, Knowles JD, Halsall A, Haselden JN, Nicholls AW, Wilson ID, Kell DB, Goodacre R. Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protc, 2011; 30: 1060-1083","DOI":"10.1038\/nprot.2011.335"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Blanchard J. Evaluation of the relative efficacy of various techniques for deproteinizing plasma samples prior to high-performance liquid chromatographic analysis. J Chromatogr, 1981; 226: 455-460","DOI":"10.1016\/S0378-4347(00)86080-6"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Polson C, Sarkar P, Incledon B, Raguvaran V, Grant R. Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci, 2003; 785: 263-275","DOI":"10.1016\/S1570-0232(02)00914-5"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18) Katakami N, Mita T, Gosho M, Takahara M, Irie Y, Yasuda T, Matsuoka TA, Osonoi T, Watada H, Shimomura I. Clinical utility of carotid ultrasonography in the prediction of cardiovascular events in patients with diabetes - a combined analysis of data obtained in five longitudinal studies. J Atheroscler Thromb, 2018; doi: 10.5551\/jat.43141","DOI":"10.5551\/jat.43141"},{"key":"19","unstructured":"19) O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med, 1999; 340: 14-22"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and metaanalysis. Circulation, 2007; 115: 459-467","DOI":"10.1161\/CIRCULATIONAHA.106.628875"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation, 2000; 101: 1899-1906","DOI":"10.1161\/01.CIR.101.16.1899"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr., Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation, 2000; 101: 948-954","DOI":"10.1161\/01.CIR.101.9.948"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Reddivari L, Sapkota BR, Rudraraju A, Liang Y, Aston C, Sidorov E, \u00b7 Vanamala JKP, Sanghera DK. Metabolite signatures of diabetes with cardiovascular disease: a pilot investigation. Metabolomics, 2017; 13: 154","DOI":"10.1007\/s11306-017-1278-8"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Lin CJ, Liu HL, Pan CF, Chuang CK, Jayakumar T, Wang TJ, Chen HH, Wu CJ. Indoxyl sulfate predicts cardiovascular disease and renal function deterioration in advanced chronic kidney disease. Arch Med Res, 2012; 43: 451-456","DOI":"10.1016\/j.arcmed.2012.08.002"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Hung SC, Kuo KL, Wu CC, Tarng DC. Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease. J Am Heart Assoc, 2017; 6: e005022","DOI":"10.1161\/JAHA.116.005022"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Vanholder R, Schepers E, Pletinck A, Nagler EV, Glorieux G. The Uremic Toxicity of Indoxyl Sulfate and p-Cresyl Sulfate: A Systematic Review. J Am Soc Nephrol, 2014; 25: 1897-1907","DOI":"10.1681\/ASN.2013101062"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Sato B, Yoshikawa D, Ishii H, Kikuchi R, Arima T, Takeshita K, Inoue Y, Suzuki S, Tanaka M, Kumagai S, Matsumoto M, Hayashi M, Ando H, Amano T, Matsubara T, Niwa T, Murohara T. Indoxyl sulfate, a uremic toxin, and carotid intima-media thickness in patients with coronary artery disease. Int J Cardiol, 2013; 163: 214- 216","DOI":"10.1016\/j.ijcard.2012.06.094"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Ramezani A, Massy ZA, Meijers B, Evenepoel P, Vanholder R, Raj DS. Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target. Am J Kidney Dis, 2016; 67: 483-489","DOI":"10.1053\/j.ajkd.2015.09.027"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Sabatino A, Regolisti G, Brusasco I, Cabassi A, Morabito S, Fiaccadori E. Alterations of intestinal barrier and microbiota in chronic kidney disease. Nephrol Dial Transplant, 2015; 30: 924-933","DOI":"10.1093\/ndt\/gfu287"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Sabatino A, Regolisti G, Cosola C, Gesualdo L, Fiaccadori E. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease. Curr Diab Rep, 2017; 17: 16","DOI":"10.1007\/s11892-017-0841-z"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Sato J, Kanazawa A, Ikeda F, Yoshihara T, Goto H, Abe H, Komiya K, Kawaguchi M, Shimizu T, Ogihara T, Tamura Y, Sakurai Y, Yamamoto R, Mita T, Fujitani Y, Fukuda H, Nomoto K, Takahashi T, Asahara T, Hirose T, Nagata S, Yamashiro Y, Watada H. Gut Dysbiosis and Detection of \u201cLive Gut Bacteria\u201d in Blood of Japanese Patients With Type 2 Diabetes. Diabetes Care, 2014; 37: 2343-2350","DOI":"10.2337\/dc13-2817"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Omori K, Katakami N, Yamamoto Y, Ninomiya H, Takahara M, Matsuoka TA, Bamba T, Fukusaki E, Shimomura I. Identification of Metabolites Associated with Onset of CAD in Diabetic Patients Using CE-MS Analysis: A Pilot Study. J Atheroscler Thromb, 2019; 26: 233-245","DOI":"10.5551\/jat.42945"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/27\/10\/27_52506\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T03:13:33Z","timestamp":1601694813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/27\/10\/27_52506\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.52506","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]}}}